TORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced the expansion of its market leading product portfolio with the launch of new flower genetics by best-selling cannabis lifestyle brand, Redecan. Redecan introduces a limited-edition series of exclusive whole flower cannabis genetics including; King Sherb and Animal RNTZ, two high-quality Indica strains meticulously cultivated by master growers. These new cannabis strains join the brand’s award-winning product portfolio, including consumer favorites like Wappa, Cold Creek Kush and Glueberry OG.
Redecan’s new limited-edition cannabis whole flower lineup includes:
- King Sherb – Redecan’s new crowning achievement. This royal cultivar reigns supreme with a lineage combining the genetics of OGKB V2.1 and Blue Sherbert for the ultimate blend of top-notch aromatics reminiscent of the infamous Pink Kush. With primary terpenes including limonene, caryophyllene, myrcene, and farnesene, King Sherb’s has distinct scents of pungent funk, cream, and diesel. Available in Ontario, Alberta, and coming soon to British Columbia.
- Animal RNTZ – the result of primarily crossing Animal Cookies and Runtz. True to its lineage, it delivers fruity tartness and a sweet and sour aroma informed by high levels of caryophyllene, limonene, ocimene and bisabolol. Sporting dense, tight buds, this potent strain achieves remarkable THC levels. Animal RNTZ is now available in 3.5g & 14g format in Ontario, Alberta, and coming soon to British Columbia.
Don’t miss out on experiencing these new, limited-edition strains from Redecan. You can find King Sherb and Animal RNTZ at authorized cannabis retailers in Ontario and Alberta, with availability in British Columbia coming soon. For more exciting product releases and formats from Redecan, visit https://redecan.ca/.
About Tilray Brands
Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.
For more information on Tilray, visit Tilray Brands, Inc. and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.